The process is usually simple: At InjectCo, consultations are available across Texas locations
The GHK-Cu half life is so remarkably short that it demands a completely different approach compared to more stable peptides
This is the window that the Finkley 2005 trial captured, and the Carey/Pickart ultrasound work confirmed at the structural level: an average 28% increase in collagen density, with top responders at 51%
TB-500 TB-500 is a synthetic peptide fragment designed to mimic the active region of Thymosin Beta-4, but with greater stability and shelf life, making it more practical for research storage and use
Real Longevity Strategy: Peptides are not a replacement for sleep, resistance training, protein intake, metabolic health, hormone assessment, and inflammation control
Frequently Asked Questions About GHK-Cu Peptide References Pickart L et al